HYBRID TARGET ANALYTE RESPONSIVE POLYMER SENSOR WITH OPTICAL AMPLIFICATION

• US 20110212463A1
• Filed: 02/25/2011
• Published: 09/01/2011
• Est. Priority Date: 02/25/2010
• Status: Active Grant

• Current Assignee: University of Rochester
• Original Assignee: University of Rochester
• Inventors: DELOUISE, Lisa, BONANNO, Lisa
• Granted Patent: US 8,841,137 B2
• Time in Patent Office: Days
• US Class Current: 435/7.1
• CPC Class Codes: G01N 33/54306 Solid-phase reaction mechanisms
• CPC Class Codes: G01N 33/54386 Analytical elements
• CPC Class Codes: Y10S 436/805 Optical property

Abstract

Disclosed is a product that includes an optical sensor; a target-responsive hydrogel matrix on a surface of the optical sensor (where the hydrogel matrix comprises one or more target-specific receptors and one or more target analogs), and one or more high refractive index nanoparticles within the hydrogel matrix, where a detectable change occurs in a refractive index of the hydrogel matrix when contacted with one or more target molecules. Sterile packages and detection devices containing the product, and methods of detecting a target molecule using the product, are also disclosed.

Claims

1. A product comprising:

an optical sensor;

a target-responsive hydrogel matrix on a surface of the optical sensor, wherein the hydrogel matrix comprises one or more target-specific receptors and one or more target analogs; and

one or more high refractive index nanoparticles within the hydrogel matrix;

wherein a detectable change occurs in a refractive index of the hydrogel matrix when contacted with one or more target molecules.

2. The product according to claim 1, wherein the optical sensor is a porous material.

3. The product according to claim 1, wherein the porous material is a porous semiconductor material comprising p-doped silicon, n-doped silicon, intrinsic or undoped silicon, intrinsic or undoped germanium, doped germanium, a semiconductor material based on a Group II material, a material based on Group III-V materials, a semiconductor material based on a Group VI material, or combinations thereof.

4. The product according to claim 3, wherein the porous semiconductor material is doped with one or more of B, Al, Ga, In, P, As, Sb, and Ge.

5. The product according to claim 3, wherein the porous semiconductor material is silicon.

6. The product according to claim 2, wherein the porous material is selected from the group consisting of single layer materials, double layer architectures, mirrors, microcavities, rugate filters, and stacked combinations of these.

7. The product according to claim 6, wherein the porous material comprises a stack of upper and lower layers including strata of alternating porosity of distinct or graded refractive index, and optionally including a central layer interposed between the upper and lower layers.

8. The product according to claim 2, wherein the porous material is nanoporous, microporous, or macroporous.

9. The product according to claim 2, wherein the porous material is formed from silicon wafers or silicon films on a support.

10. The product according to claim 1, wherein the hydrogel matrix is selected from the group consisting of synthetic hydrogels, natural hydrogels, and mixtures thereof.

11. The product according to claim 10, wherein the hydrogel matrix is selected from the group of polyacrylamide hydrogels, polyvinyl hydrogels, polylactic acid hydrogels, polyglycolic acid hydrogels, polyethylene glycol hydrogels, agarose hydrogels, collagen hydrogels, acrylic hydrogels, acrylated quaternary ammonium monomeric hydrogels, polyurethane hydrogels, organic/inorganic hybrid hydrogels, cross-linked keratin hydrogels, polyethylene amines, chitosan, and combinations thereof.

12. The product according to claim 10, wherein the hydrogel matrix comprises one or more polymers having side groups that can be used to tether bioactive reagents.

13. The product according to claim 1, wherein the hydrogel matrix comprises one or more agents selected from the group consisting of antimicrobial agents, bacteriostatic agents, antiviral agents, and antifungal agents.

14. The product according to claim 1, wherein the one or more receptors and the one or more target analogs form one or more reversible crosslinks within the hydrogel matrix, wherein binding between at least one of the target molecules and at least one of the receptors breaks at least one of the reversible crosslinks, resulting in swelling of the hydrogel matrix and a change in the refractive index of the hydrogel matrix.

15. The product according to claim 14, wherein the one or more high refractive index nanoparticles are nonspecifically encapsulated in the hydrogel matrix, and wherein said swelling of the hydrogel matrix results in release of at least one of the nanoparticles from the hydrogel matrix, whereby a change in the refractive index of the hydrogel matrix occurs.

16. The product according to claim 14, wherein the one or more receptors and/or the one or more target analogs are coupled to the one or more nanoparticles, the one or more receptors, the one or more target analogs, and the one or more nanoparticles collectively forming the one or more reversible crosslinks within the hydrogel matrix, wherein binding between at least one of the target molecules and at least one of the receptors further results in displacement and release of at least one of the nanoparticles from the hydrogel matrix, whereby a change in the refractive index of the hydrogel matrix occurs.

17. The product according to claim 1, wherein the one or more receptors or the one or more target analogs are coupled to the hydrogel matrix and the other of the one or more receptors and the one or more target analogs are coupled to the one or more nanoparticles, whereby the one or more nanoparticles are reversibly bound to the hydrogel matrix, wherein binding between at least one of the target molecules and at least one of the receptors results in displacement and release of at lest one of the nanoparticles from the hydrogel matrix, whereby a change in the refractive index of the hydrogel matrix occurs.

18. The product according to claim 1, wherein the one or more receptors are monovalent.

19. The product according to claim 1, wherein the one or more receptors are multivalent.

20. The product according to claim 1, wherein the one or more receptors are selected from the group consisting of non-polymeric small chemical molecule complexes, peptides, polypeptides, proteins, peptide-mimetic compounds, antibody complexes, oligonucleotides, enzymes, and ribozymes.

21. The product according to claim 20, wherein the one or more receptors are selected from the group consisting of receptors for cell surface molecules, lipid A receptors, antibodies or fragments thereof, peptide monobodies, lipopolysaccharide-binding polypeptides, peptidoglycan-binding polypeptides, carbohydrate-binding polypeptides, phosphate-binding polypeptides, nucleic acid-binding polypeptides, and polypeptides that bind an organic warfare agent.

22. The product according to claim 1, wherein the target molecule is selected from the group consisting of antigens, antibodies, proteins, glycoproteins, peptidoglycans, carbohydrates, lipoproteins, lipoteichoic acid, lipid A, phosphates, nucleic acids, pathogens, host markers of infection, organic warfare agents, organic compounds, drugs of abuse, opiates, pain killers, antimicrobial peptides, immune function markers, cancer markers, and disease markers.

23. The product according to claim 1, wherein the one or more high refractive index nanoparticles are selected from the group consisting of InP, PbS, PbSe, CdSe, ZnS, CdSe core ZnS shell, CdTe, CdS, Si, FexOy, TiO2, AlxOy, ZnOs, SiC, and TiC.

24. The product according to claim 1, wherein the one or more high refractive index nanoparticles have a refractive index greater than 1.5, at least 1.7, greater than 2.0, at least 2.5, or at least 3.6.

25. The product according to claim 1, wherein the one or more high refractive index nanoparticles have a diameter of about 5 to about 50 nm.

26. The product according to claim 2, wherein the one or more high refractive index nanoparticles are small enough to diffuse out of the porous semiconductor material.

27. The product according to claim 1, wherein the detectable change in the refractive index occurs at a target molecule concentration of between picograms per milliliter and milligrams per milliliter.

28. The product according to claim 27, wherein the detectable change in the refractive index occurs at a target molecule concentration of picograms per milliliter.

29. The product according to claim 27, wherein the detectable change in the refractive index occurs at a target molecule concentration of nanograms per milliliter.

30. The product according to claim 1, wherein the detectable change in the refractive index occurs in the visible range.

31. The product according to claim 1, wherein the detectable change in the refractive index of the hydrogel matrix is amplified by the presence of the high refractive index nanoparticles.

32. The product according to claim 1 further comprising:

a vapor barrier applied to at least one side of the hydrogel matrix.

33. The product according to claim 1 further comprising:

a release layer contacting at least one side of the product.

34. A sterile package containing a sterile product according to claim 1.

35. A detection device comprising:

a product according to claim 1, and

a source of illumination positioned to illuminate the product.

36. The detection device according to claim 35 further comprising a detector positioned to capture light reflected from the product and to detect changes in the refractive index of the hydrogel matrix.

37. The detection device according to claim 36, wherein the detector is a spectral analyzer of a human eye.

38. A method of detecting a target molecule comprising:

exposing a product according to claim 1 to a sample under conditions effective to allow binding of a target molecule in the sample to the one or more receptors; and

determining whether a change in refractive index of the hydrogel matrix occurs following said exposing, whereby a change in refractive index indicates the presence of the target molecule in the sample.

39. The method according claim 38, wherein said determining comprises:

measuring a first refractive index before said exposing;

measuring a second refractive index after said exposing; and

comparing the first and second refractive indices.

40. The method according to claim 39, wherein said measuring is carried out using a light source and a spectral analyzer.

41. The method according to claim 39, wherein said measuring is carried out using a light source and a spectral analyzer.

42. The method according to claim 38, wherein the sample is blood, water, a suspension of solids in an aqueous solution, or a tissue homogenate.

43. The method according to claim 42, wherein the solids suspended in the aqueous solution are food particles, soil particles, or a cell suspension from a clinical isolate.

44. The method according to claim 38 further comprising:

quantifying the amount of target molecule(s) present in the sample based on the degree of change in refractive index that occurs.